Development of small molecular inhibitor specifically targeting MTORC2 for cancer therapeutics: Development of targeted anti-cancer strategy

Accessibility Controls

Principal Investigator

Dr. Smrati Bhadauria

Scientist, Central Drug Research Institute (CDRI), Lucknow, Uttar Pradesh

Area of Research

Pharmaceutical Sciences

Focus Area

Cancer therapeutics

Start Date

2017

Sanction Amount

₹ 40.83 L

Contact

smriti_bhadauria@cdri.res.in

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

Publications

No. of Patents

Filed : 00

Grant : 00

Accessibility Controls